Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases

World Journal of Surgery

Volumn 36, Issue 1, 2012, Pages 157-163

  Spelt, Lidewij ^a   Hermansson, Lina ^a   Tingstedt, Bobby ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; COLORECTAL TUMOR; EVALUATION; FEMALE; HUMAN; LENGTH OF STAY; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; STATISTICS; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD LOSS, SURGICAL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866007692     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1342-x     Document Type: Article

References (34)

1. Statistics Sweden. http://www.scb.se, accessed September 15, 2010
2. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59:225-249
3. American Cancer Society (2009). Cancer facts and figures. American Cancer Society, Atlanta, GA. Available at: http://www.cancer.org/. Accessed September 15, 2010
4. Leporrier J, Maurel J, Chiche L et al (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465-474
5. Bengmark S, Hafström L (1969) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198-202
6. Bengtsson G, Carlsson G, Hafström L et al (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586-589
7. Tan MC, Castaldo ET, Gao F et al (2008) A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. J Am Coll Surg 206:857-868
8. Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125-135
9. Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-825
10. Fernandez FG, Drebin JA, Linehan DC et al (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438-447
11. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766
12. Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938-946
13. Doci R, Gennari L, Bignami P et al (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78:797-801
14. Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84:1136-1140
15. Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8:347-353
16. Ito K, Govindarajan A, Ito H et al (2010) Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J 16:103-110
17. Pozzo C, Basso M, Cassano A et al (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15:933-939
18. Kooby DA, Fong Y, Suriawinata A et al (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7:1034-1044
19. Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082-1088
20. Fernandez FG, Ritter J, Goodwin JW et al (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853
21. Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072
22. Rubbia-Brandt L, Mentha G, Terris B (2006) Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg 202:199-200
23. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213
24. Zeiss J, Merrick HW, Savolaine ER et al (1990) Fatty liver change as a result of hepatic artery infusion chemotherapy. Am J Clin Oncol 13:156-160
25. Sorensen P, Edal AL, Madsen EL et al (1995) Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil. Cancer 15 75:2592-2596
26. Didolkar MS, Fitzpatrick JL, Elias EG et al (1989) Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 169:17-26
27. Pocard M, Vincent-Salomon A, Girodet J et al (2001) Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology 48:1406-1408
28. Gomez D, Malik HZ, Bonney GK et al (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94:1395-1402
29. Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990 s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46
30. Scoggins CR, Campbell ML, Landry CS et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16:35-41
31. Welsh FK, Tilney HS, Tekkis PP et al (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96:1037-1042
32. Mehta NN, Ravikumar R, Coldham CA et al (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782-786
33. Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-1016
34. Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-520